Zobrazeno 1 - 4
of 4
pro vyhledávání: '"E. A. Tyutyumova"'
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 11, Iss 1, Pp 72-78 (2019)
Objective: to assess changes in the vascular platelet component of hemostasis in patients in different recovery periods of ischemic stroke (IS).Patients and methods. The investigation enrolled 73 patients with prior IS. According to the remoteness of
Externí odkaz:
https://doaj.org/article/0dcc218eab3640ffbd6f7ca8c9135bee
Publikováno v:
Медицинский совет, Vol 0, Iss 8, Pp 24-33 (2016)
Antiplatelet medications are essential in the primary and secondary prevention of stroke. All currently available antiplatelet drugs are platelet aggregation inhibitors acting at various points of application, but they differ in their mechanism of ac
Externí odkaz:
https://doaj.org/article/dc13da307670458f997a9362b0d51052
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 117:75
The authors present the results of domestic clinical trials on the efficacy and safety of mexidol in patients with cerebrovascular disorders including ischemic stroke (IS). The use of mexidol is associated with complete and rapid regression of the fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::172c5b3da9521574dc62c238e3c88899
https://doi.org/10.17116/jnevro20171178275-80
https://doi.org/10.17116/jnevro20171178275-80
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 116:116
High level of glucose in the blood in hypoxic-ischemic states is one of the main factors that complicates the degree of brain damage. An increased level of reactive oxygen species and impaired functioning of the endogenous antioxidant system are the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b32eafc0f94c34a704a542956629e9
https://doi.org/10.17116/jnevro201611691116-125
https://doi.org/10.17116/jnevro201611691116-125